Home / Tag Archives: HbA1c

Tag Archives: HbA1c

A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?

Clinician reviewing A1C and glycated albumin results for type 2 diabetes monitoring

A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …

Read More »

Digital Diabetes Coaching: Why an App Alone Isn’t Enough

Person with type 2 diabetes using a digital health app while receiving virtual diabetes coaching and tracking healthy lifestyle goals.

A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …

Read More »

Which Diabetes Drug Will Work Best? New Research Puts Precision Prescribing to the Test

Precision diabetes treatment concept showing sitagliptin, canagliflozin, and pioglitazone with glucose monitoring and personalized care tools.

Precision diabetes treatment aims to answer a question clinicians and patients face every day: which diabetes drug is most likely to work best for this particular person? A new analysis from the TriMaster crossover trial offers an important clue. Researchers compared several precision-medicine strategies for predicting responses to sitagliptin, canagliflozin, …

Read More »

Could We Predict Diabetic Neuropathy Years Before Symptoms Begin?

Illustration of IgG glycosylation biomarkers, laboratory blood analysis, and peripheral nerves representing early detection of diabetic neuropathy in people with diabetes.

Early detection has always been one of the biggest challenges in diabetes care. What if doctors could identify patients at high risk for diabetic neuropathy or kidney disease years before symptoms developed? That possibility is driving exciting new research into IgG glycosylation in diabetes, an emerging area that examines subtle …

Read More »

Why Some Young Adults Lose Diabetes Control After Leaving Pediatric Care

Young adult with type 1 diabetes transitioning from a pediatric diabetes clinic to an adult endocrinology practice, illustrating the challenges of the transition to adult diabetes care.

The transition from pediatric to adult diabetes care is one of the most challenging periods in the lives of young people with diabetes. While many adolescents successfully manage their condition with the support of pediatric diabetes teams, moving into adult healthcare often coincides with worsening blood glucose control, missed appointments, …

Read More »

Beyond A1C: Could Metabolic Flexibility Become the Next Major Diabetes Biomarker?

Woman exercising with healthy foods and digital metabolic pathways illustrating metabolic flexibility and fuel switching in diabetes management.

For decades, A1C has served as the gold standard for assessing long-term glucose control in people with diabetes. However, it tells only part of the story. Researchers are now exploring whether metabolic flexibility could become an important biomarker in diabetes, offering a deeper understanding of metabolic health than A1C alone. …

Read More »

Should We Be Prescribing Exercise as a Formal Diabetes Intervention?

Diabetes management tools including a prescription pad, glucose meters, teal dumbbells, jump rope, and water bottle on a wooden surface.

When treating patients with diabetes, lifestyle advice such as “eat healthy” and “stay active” is often routine. But what if we took that a step further and issued a formal exercise prescription — in other words, ordering physical activity like we would a drug? Recent research suggests that a structured …

Read More »